Teladoc Health: Teladoc Health, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025

Teladoc Health, Inc. reported earnings results for the first quarter ended March 31, 2025. For the first quarter, the company reported sales was USD 629.37 million compared to USD 646.13 million a year ago. Net loss was USD 93.01 million compared to USD 81.89 million a year ago. Basic loss per share from continuing operations was USD 0.53 compared to USD 0.49 a year ago. Diluted loss per share from continuing operations was USD 0.53 compared to USD 0.49 a year ago. Teladoc Health, Inc. reported earnings results for the first quarter ended March 31, 2025. For the first quarter, the company reported sales was USD 629.37 million compared to USD 646.13 million a year ago. Net loss was USD 93.01 million compared to USD 81.89 million a year ago. Basic loss per share from continuing operations was USD 0.53 compared to USD 0.49 a year ago. Diluted loss per share from continuing operations was USD 0.53 compared to USD 0.49 a year ago.